Routine neonatal screening is anything but routine. This week, we dive into the data on QTc screening, revealing a startling 95% normalization rate in follow-up cases. We then shift focus to high-priority threats: NICU admissions linked to maternal COVID-19, genetic precision in treating alloimmune thrombocytopenia, and the revolutionary potential of salivary PCR for CMV. We explore how balancing sensitivity vs. specificity and addressing economic disparities are redefining the future of infant health.

Respiratory distress syndrome remains one of the leading risk factors for infant mortality, but recent research is transforming our understanding and treatment of this critical condition. We discuss systematic reviews, qualitative studies on CPAP implementation in low-resource settings, predictive biomarkers like sFlt-1/PlGF in IUGR, and innovative surgical techniques such as fetoscopic two-layer closure. Discover how personalized approaches, integration of new technologies, and careful consideration of healthcare contexts are revolutionizing neonatal care.

Despite global immunization campaigns, massive gaps remain for the most vulnerable children. This episode dives into emerging research on vaccine inequities, hesitancy, and cutting-edge innovations that could redefine protection worldwide.

Explore the latest research on autism spectrum disorder, from environmental toxins and prenatal factors to innovative interventions improving early detection and outcomes.

From family involvement that triples treatment success to cutting-edge fetal monitoring and preterm survival breakthroughs—this episode unpacks the latest data reshaping maternal and neonatal care.

Over 3 million newborns face sepsis every year — but new research is reshaping how we detect and treat this life-threatening condition. From advanced biomarkers to metagenomic sequencing, and from antimicrobial resistance to maternal transmission patterns, this episode explores the evolving frontiers of neonatal care.